Filed before 2025Filed 20 April 2017
Velicept Therapeutics, Inc. has sold $18.4M so far
Velicept Therapeutics, Inc., a pharmaceuticals company based in Malvern, PA, has sold $18.4M so far in its equity round, according to a filing dated 20 April 2017.
Raises filed before 2025 are not checked for a public announcement.
- Filed
- 20 April 2017
- First filed
- 1 December 2015
- Round
- Equity round (amended filing)
- Amount sold
- $18.4M
- Offering size
- $26.3M
- Investors so far
- 25
- Based in
- Malvern, PA
Investors on the board
- Metamorphic Ventures
- Metamorphic Ventures FD
- Valence Advantage Life Sciences
- Hibiscus Capital Management
- NeXeption Capital
Firms come from the venture funds whose filings name a director of this company.
Who is on the board
4 directors of this company are named on venture funds' filings. Sign in free with Google to see who, the full filing, and a short list of rounds like this each morning.
Sign in with GoogleHow it compares
Larger than 80% of the 1,645 tracked raises with an amount filed in 2017, and than 58% of the 40 in pharmaceuticals.
Velicept Therapeutics, Inc. in public filings
| Filed | Filing | Sold | Raise |
|---|---|---|---|
| 19 Nov 2019 | New filing | $6M | Another raise |
| 18 Jul 2018 | New filing | $15.5M | Another raise |
| 20 Apr 2017 | Amended filing | $18.4M | This raise |
| 1 Dec 2015 | New filing | $12M | This raise |
More with Metamorphic Ventures on the board
Other unannounced rounds
- DVx Atomic Co.$18.5M
- Aperio Systems, Inc.$1.6M
- Twin Health, Inc.$59M
- Scoring Factory AI Inc.$500K
- Royal & Pelham, Inc.$5.4M
- SPECTRA Holdings US, Ltd.$2.5M
Seen it announced?
Send the link and the check will look at it.